000 01162 a2200361 4500
005 20250512042945.0
264 0 _c19890607
008 198906s 0 0 eng d
022 _a0065-2598
024 7 _a10.1007/978-1-4613-1057-0_9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNick, H P
245 0 0 _aDevelopment of Eglin c as a drug: pharmacokinetics.
_h[electronic resource]
260 _bAdvances in experimental medicine and biology
_c1988
300 _a83-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCricetinae
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aLeukocyte Elastase
650 0 4 _aPancreatic Elastase
_xantagonists & inhibitors
650 0 4 _aPapio
650 0 4 _aProteins
_xpharmacokinetics
650 0 4 _aRabbits
650 0 4 _aRats
650 0 4 _aSerpins
650 0 4 _aSpecies Specificity
650 0 4 _aSwine
700 1 _aProbst, A
700 1 _aSchnebli, H P
773 0 _tAdvances in experimental medicine and biology
_gvol. 240
_gp. 83-8
856 4 0 _uhttps://doi.org/10.1007/978-1-4613-1057-0_9
_zAvailable from publisher's website
999 _c3251288
_d3251288